Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006-2019. temporal progression of serotypes distribution and antibiotic resistance.

Zintgraff, J., Gagetti, P., Napoli, D., Sanchez Eluchans, N., Irazu, L., Moscoloni, M., Regueira, M., Lara, C. S., Corso, A., (2022). Vaccine 40(3), 459-470. Elsevier Ltd, Oxford, UK. English language

Comparative characteristics of the background and blood test findings in adults with pneumococcal pneumonia and invasive pneumococcal disease: a retrospective study.

Tsuchiya, M., Miyazaki, H., Takata, M., Shibuya, R., Chang Bin, Ubukata, K., Matsumoto, T., Nakamura, S., (2022). Journal of Infection and Chemotherapy 28(3), 420-425. Elsevier, Oxford, UK. English language

Streptococcus pneumoniae serotypes associated with death, South Africa, 2012-2018.

Müller, A., Kleynhans, J., Gouveia, L. de, Meiring, S., Cohen, C., Hathaway, L. J., Gottberg, A. von, (2022). Emerging Infectious Diseases 28(1), 166-179. National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, USA. English language

Differential impact of nonpharmaceutical interventions on the epidemiology of invasive bacterial infections in children during the Coronavirus disease 2019 pandemic.

Kim YeKyung, Choi YounYoung, Lee Hyunju, Song EunSong, Ahn JongGyun, Park SuEun, Lee Taekjin, Cho HyeKyung, Lee JiNa, Kim YaeJean, Jo DaeSun, Kang HyunMi, Lee JoonKee, Kim ChunSoo, Kim DongHyun, Kim HwangMin, Choi JaeHong, Eun ByungWook, Kim NamHee, Cho EunYoung, Kim YunKyung, Oh ChiEun, Kim KyungHyo, Choi EunHwa, (2022). Pediatric Infectious Disease Journal 41(2), 91-96. Lippincott Williams & Wilkins, Inc., Hagerstown, USA. English language

Burden of invasive pneumococcal disease (IPD) over a 10-year period in Bogotá, Colombia.

Severiche-Bueno, D. F., Severiche-Bueno, D. F., Bastidas, A., Caceres, E. L., Silva, E., Lozada, J., Gomez, S., Vargas, H., Viasus, D., Reyes, L. F., (2021). International Journal of Infectious Diseases 105, 32-39. Elsevier Ltd, Oxford, UK. English language

Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006-18: prospective observational time-series and case-control studies.

Bar-Zeev, N., Swarthout, T. D., Everett, D. B., Alaerts, M., Msefula, J., Brown, C., Bilima, S., Mallewa, J., King, C., Gottberg, A. von, Verani, J. R., Whitney, C. G., Mwansambo, C., Gordon, S. B., Cunliffe, N. A., French, N., Heyderman, R. S., (2021). Lancet Global Health 9(7), e989-e998. Elsevier, Oxford, UK. English language

Effectiveness of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Greenland.

Nikolova, K. A., Andersson, M., Slotved, H. C., Koch, A., (2021). Vaccines 9(10) MDPI AG, Basel, Switzerland. English language

Using genomics to examine the persistence of Streptococcus pneumoniae serotype 19A in Ireland and the emergence of a sub-clade associated with vaccine failures.

Corcoran, M., Mereckiene, J., Cotter, S., Murchan, S., Lo, S. W., McGee, L., Breiman, R. F., Cunney, R., Humphreys, H., Bentley, S. D., Gladstone, R. A., (2021). Vaccine 39(35), 5064-5073. Elsevier Ltd, Oxford, UK. English language

Pneumokokkenimpfstoffe. / Pneumococcal vaccination.

Pletz, M. W., Bahrs, C., (2021). Internist (Berlin) 62(8), 807-815. Springer-Verlag GmbH, Berlin, Germany. German language

Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: an observational study.

Chan, J., Gidding, H. F., Blyth, C. C., Parveen Fathima, Sanjay Jayasinghe, McIntyre, P. B., Moore, H. C., Mulholland, K., Nguyen, C. D., Andrews, R., Russell, F. M., (2021). PLoS Medicine 18(8) Public Library of Sciences (PLoS), San Francisco, USA. English language